Treatment of pneumocystis carinii pneumonia. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Lung Sputum Pulmonary Alveoli CD4-Positive T-Lymphocytes Macrophages, Alveolar

Organisms8

Pneumocystis Pneumocystis carinii Pneumocystis jirovecii Mice, SCID Rats, Inbred Strains Rats, Sprague-Dawley HIV-1 Mice, Inbred BALB C

Diseases24

Pneumonia, Pneumocystis Pneumocystis Infections AIDS-Related Opportunistic Infections Opportunistic Infections Pneumonia Acquired Immunodeficiency Syndrome Pneumonia, Bacterial Toxoplasmosis, Cerebral AIDS-Related Complex HIV Infections Pneumonia, Viral HIV Seropositivity Pneumonia, Pneumococcal Sarcoma, Kaposi Cryptogenic Organizing Pneumonia Disease Models, Animal Hypergammaglobulinemia Pneumonia, Staphylococcal Lung Diseases Pneumonia, Ventilator-Associated Pneumonia, Aspiration Community-Acquired Infections Pneumonia, Mycoplasma Lung Diseases, Interstitial

Chemicals and Drugs34

Pentamidine Trimethoprim-Sulfamethoxazole Combination Dapsone Sulfamethoxazole Atovaquone Trimethoprim Amidines Anti-Infective Agents Sulfamethoxypyridazine Naphthoquinones Methenamine Antibodies, Fungal Aerosols Cortisone DNA, Fungal Antifungal Agents Gallium Radioisotopes Dihydropteroate Synthase Drug Combinations Antigens, Fungal Methylprednisolone Eflornithine Zidovudine Pulmonary Surfactants Adrenal Cortex Hormones Technetium Tc 99m Pentetate beta-Glucans Dexamethasone Quinaldines Folic Acid Antagonists Trimetrexate Fungal Proteins Pyrimethamine Immunosuppressive Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment25

Bronchoalveolar Lavage Fluid Immunosuppression Bronchoalveolar Lavage CD4 Lymphocyte Count Fatal Outcome Polymerase Chain Reaction Bronchoscopy Disease Models, Animal Drug Therapy, Combination Chemoprevention Evaluation Studies as Topic Antibiotic Prophylaxis Retrospective Studies Administration, Inhalation Prospective Studies Leukocyte Count Lymphocyte Depletion Incidence Random Allocation Staining and Labeling Drug Administration Schedule Sensitivity and Specificity Survival Rate Antiretroviral Therapy, Highly Active Risk Factors

Phenomena and Processes8

Immunocompromised Host CD4 Lymphocyte Count HIV Seronegativity Immunocompetence Leukocyte Count Time Factors Sensitivity and Specificity Base Sequence

Information Science5

Fatal Outcome Molecular Sequence Data Incidence Survival Rate Base Sequence

Health Care9

Fatal Outcome Evaluation Studies as Topic Retrospective Studies Prospective Studies Incidence Random Allocation Sensitivity and Specificity Survival Rate Risk Factors

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care Geographicals

Pneumonia, Pneumocystis Pneumocystis Pneumocystis carinii Pentamidine Pneumocystis Infections Trimethoprim-Sulfamethoxazole Combination Dapsone AIDS-Related Opportunistic Infections Sulfamethoxazole Pneumocystis jirovecii Opportunistic Infections Atovaquone Trimethoprim Pneumonia Amidines Acquired Immunodeficiency Syndrome Anti-Infective Agents Sulfamethoxypyridazine Lung Bronchoalveolar Lavage Fluid Naphthoquinones Methenamine Pneumonia, Bacterial Immunosuppression Immunocompromised Host Antibodies, Fungal Aerosols Cortisone DNA, Fungal Toxoplasmosis, Cerebral Antifungal Agents Sputum AIDS-Related Complex Gallium Radioisotopes Bronchoalveolar Lavage HIV Infections Pneumonia, Viral Dihydropteroate Synthase HIV Seropositivity CD4 Lymphocyte Count Mice, SCID Pneumonia, Pneumococcal Drug Combinations Fatal Outcome HIV Seronegativity Polymerase Chain Reaction Pulmonary Alveoli Antigens, Fungal Bronchoscopy Sarcoma, Kaposi Methylprednisolone Eflornithine Zidovudine Cryptogenic Organizing Pneumonia Disease Models, Animal Immunocompetence Drug Therapy, Combination Chemoprevention Rats, Inbred Strains Pulmonary Surfactants Evaluation Studies as Topic Antibiotic Prophylaxis Adrenal Cortex Hormones Technetium Tc 99m Pentetate Retrospective Studies Administration, Inhalation Prospective Studies Hypergammaglobulinemia beta-Glucans Pneumonia, Staphylococcal Leukocyte Count Dexamethasone Molecular Sequence Data Quinaldines Lymphocyte Depletion Lung Diseases Folic Acid Antagonists CD4-Positive T-Lymphocytes Rats, Sprague-Dawley Trimetrexate Incidence London Pneumonia, Ventilator-Associated Fungal Proteins HIV-1 Random Allocation Macrophages, Alveolar Staining and Labeling Time Factors Pneumonia, Aspiration Drug Administration Schedule Sensitivity and Specificity Mice, Inbred BALB C Survival Rate Antiretroviral Therapy, Highly Active Pyrimethamine Immunosuppressive Agents Risk Factors Base Sequence Community-Acquired Infections

No FAQ available that match "treatment of pneumocystis carinii pneumonia"